Journal of Cancer Research and Therapeutics · 2021 · 10 citations · 19 references
MedicineOncologyPathologyMolecular OncologyNeoplasiaTumor PathologyImmunohistochemistryLung CancerMalignant NeoplasmsNeuroendocrine TumorsSquamous Cell CarcinomaTumor MarkersCarcinoid Tumor DiagnosisDiagnostic ImmunohistochemistryImmunohistochemistry AssaysLung AdenocarcinomaLung Cancer PathologyLung Squamous Cell CarcinomaPulmonary Neuroendocrine TumorsSquamous Cell Carcinoma Pathology
OBJECTIVES: The objective of the evaluate was to study and determine the usefulness of immunohistochemistry (IHC) staining in neoplastic lung lesions. MATERIALS AND METHODS: We evaluated seven IHC stains in fifty lung cancers that included adenocarcinoma (AC), squamous cell carcinoma (SCC), small cell carcinoma, and carcinoid tumors. RESULTS: P63 was expressed in all the cases of SCCs and thyroid transcription factor-1 (TTF-1) was expressed in all cases of ACs. CK 5/6 was expressed in 77.77% of SCCs and CK 7 was expressed in 92.59% of ACs. Synaptophysin and chromogranin-A were expressed in 100% of neuroendocrine (NE) carcinomas. CONCLUSION: P63 and TTF-1 are sensitive markers for SCCs and ACs. Synaptophysin and Chromogranin-A are sensitive markers for NE carcinomas.
19
William D. Travis, Élisabeth Brambilla, Masayuki Noguchi et al. · Archives of Pathology & Laboratory Medicine · 2012 · 414 citations · Full text
Andrew G. Nicholson, David González de Castro, Pallav L. Shah et al. · Journal of Thoracic Oncology · 2010 · 213 citations · Full text